← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,142 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ALDS
APPlife Digital Solutions Inc
Deeply overvalued
Consumer Cyclical
Price$1.00
Model IV$0.25
P/IV4.04
Premium +304% Return to IV: -75.3%
Market implies +25.8%/yr vs model +50.0% · below model
ALDX
Aldeyra Therapeutics, Inc.
Valuation N/A
Healthcare
Price$0.92
Model IV—
P/IV—
Limited data — see page
ALEC
Alector, Inc.
Valuation N/A
Healthcare
Price$2.08
Model IV—
P/IV—
Market implies +54.9%/yr
ALF
Centurion Acquisition Corp.
Valuation N/A
Financial Services
Price$10.92
Model IV—
P/IV—
Limited data — see page
ALFUU
Centurion Acquisition Corp.
Valuation N/A
Financial Services
Price$10.91
Model IV—
P/IV—
Limited data — see page
ALFUW
Centurion Acquisition Corp.
Valuation N/A
Financial Services
Price$0.19
Model IV—
P/IV—
Limited data — see page
ALGS
Aligos Therapeutics, Inc.
Valuation N/A
Healthcare
Price$5.34
Model IV—
P/IV—
Market implies +41.6%/yr
ALIS
Calisa Acquisition Corp
Valuation N/A
Technology
Price$10.07
Model IV—
P/IV—
Limited data — see page
ALISR
Calisa Acquisition Corp
Valuation N/A
Technology
Price$0.79
Model IV—
P/IV—
Limited data — see page
ALISU
Calisa Acquisition Corp
Valuation N/A
Technology
Price$23.10
Model IV—
P/IV—
Limited data — see page
ALLR
Allarity Therapeutics, Inc.
Valuation N/A
Healthcare
Price$0.99
Model IV—
P/IV—
Market implies +53.9%/yr
ALMU
Aeluma, Inc.
Valuation N/A
Technology
Price$11.40
Model IV—
P/IV—
Market implies +56.3%/yr
ALOT
ALOT
Valuation N/A
Price$28.99
Model IV—
P/IV—
Limited data — see page
ALOV
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Valuation N/A
Financial Services
Price$10.02
Model IV—
P/IV—
Limited data — see page
ALOVU
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Valuation N/A
Financial Services
Price$10.06
Model IV—
P/IV—
Limited data — see page
ALOVW
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Valuation N/A
Financial Services
Price$0.38
Model IV—
P/IV—
Limited data — see page
ALP
Alpha Compute Corp
Valuation N/A
Financial Services
Price$3.97
Model IV—
P/IV—
Limited data — see page
ALPS
Alps Group Inc
Valuation N/A
Healthcare
Price$0.37
Model IV—
P/IV—
Limited data — see page
ALTG
ALTA EQUIPMENT GROUP INC.
Fairly valued
Industrials
Price$6.34
Model IV$5.91
P/IV1.06
Premium +7% Return to IV: -6.8%
Market implies +4.8%/yr vs model +7.5% · in line
ALTO
Alto Ingredients, Inc.
Valuation N/A
Basic Materials
Price$3.73
Model IV—
P/IV—
Market implies +42.9%/yr vs model +5.0% · above model
ALUB
Alussa Energy Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.18
Model IV—
P/IV—
Limited data — see page
ALVOW
Alvotech
Valuation N/A
Healthcare
Price$0.45
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
ALXO
ALX ONCOLOGY HOLDINGS INC
Valuation N/A
Healthcare
Price$1.25
Model IV—
P/IV—
Limited data — see page
ALZN
Alzamend Neuro, Inc.
Valuation N/A
Healthcare
Price$1.34
Model IV—
P/IV—
Limited data — see page
AMAN
Amanat Acquisition Corp.
Valuation N/A
Financial Services
Price$10.41
Model IV—
P/IV—
Limited data — see page
AMBO
Ambow Education Holding Ltd.
Valuation N/A
Consumer Defensive
Price$1.85
Model IV—
P/IV—
Market implies +37.5%/yr
AMBR
Amber International Holding Ltd
Deeply overvalued
Financial Services
Price$1.88
Model IV$0.42
P/IV4.26
Premium +351% Return to IV: -77.8%
Market implies +20.5%/yr vs model +2.0% · above model
AMCI
AMC Robotics Corp
Valuation N/A
Consumer Cyclical
Price$2.78
Model IV—
P/IV—
Market implies +59.6%/yr
AMIX
Autonomix Medical, Inc.
Valuation N/A
Healthcare
Price$3.11
Model IV—
P/IV—
Limited data — see page
AMOD
ALPHA MODUS HOLDINGS, INC.
Valuation N/A
Financial Services
Price$2.19
Model IV—
P/IV—
Limited data — see page
AMODW
ALPHA MODUS HOLDINGS, INC.
Deeply overvalued
Financial Services
Price$0.02
Model IV$0.01
P/IV2.45
Premium +116% Return to IV: -53.7%
AMPG
AmpliTech Group, Inc.
Undervalued
Technology
Price$2.84
Model IV$3.66
P/IV0.88
Discount 22% Return to IV: +28.7%
Market implies +0.8%/yr vs model +47.8% · below model
AMPGR
AMPGR
Valuation N/A
Price$1.25
Model IV—
P/IV—
Limited data — see page
AMPGZ
AmpliTech Group, Inc.
Deeply undervalued
Technology
Price$0.10
Model IV$3.23
P/IV0.05
Discount 97% Return to IV: +3,031.1%
Market implies -50.0%/yr vs model +47.8% · below model
AMPY
Amplify Energy Corp.
Deeply undervalued
Energy
Price$4.46
Model IV$7.72
P/IV0.54
Discount 42% Return to IV: +73.0%
Market implies -11.6%/yr vs model +0.9% · below model
AMS
AMERICAN SHARED HOSPITAL SERVICES
Deeply undervalued
Healthcare
Price$1.32
Model IV$3.57
P/IV0.40
Discount 63% Return to IV: +170.5%
Market implies -21.3%/yr vs model +12.4% · below model
AMSS
AMASS BRANDS
Valuation N/A
Consumer Defensive
Price$0.34
Model IV—
P/IV—
Limited data — see page
AMST
Amesite Inc.
Valuation N/A
Technology
Price$0.88
Model IV—
P/IV—
Market implies +31.3%/yr
AMTD
AMTD IDEA GROUP
Deeply undervalued
Financial Services
Price$0.51
Model IV$1.72
P/IV0.42
Discount 70% Return to IV: +235.9%
Market implies -22.7%/yr vs model +1.6% · below model
AMTX
AEMETIS, INC
Valuation N/A
Basic Materials
Price$1.66
Model IV—
P/IV—
Market implies +44.7%/yr vs model +5.0% · above model
AMWL
American Well Corp
Deeply overvalued
Technology
Price$12.70
Model IV$6.94
P/IV1.90
Premium +83% Return to IV: -45.4%
Market implies +9.6%/yr vs model +2.0% · above model
ANGH
Anghami Inc
Deeply overvalued
Communication Services
Price$3.77
Model IV$1.85
P/IV2.06
Premium +104% Return to IV: -51.1%
Market implies +9.7%/yr vs model +26.5% · below model
ANGHW
Anghami Inc
Valuation N/A
Communication Services
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +26.5% · below model
ANGI
Angi Inc.
Deeply overvalued
Technology
Price$6.59
Model IV$4.17
P/IV1.37
Premium +58% Return to IV: -36.7%
Market implies +2.8%/yr vs model -0.4% · above model
ANIK
Anika Therapeutics, Inc.
Deeply overvalued
Healthcare
Price$19.58
Model IV$5.90
P/IV3.54
Premium +232% Return to IV: -69.9%
Market implies +15.9%/yr vs model +2.0% · above model
ANIX
Anixa Biosciences Inc
Valuation N/A
Healthcare
Price$2.90
Model IV—
P/IV—
Market implies +150.0%/yr
ANNA
AleAnna, Inc.
Valuation N/A
Energy
Price$2.57
Model IV—
P/IV—
Market implies +54.1%/yr vs model +4.0% · above model
ANNAW
AleAnna, Inc.
Deeply overvalued
Energy
Price$0.25
Model IV$0.10
P/IV2.77
Premium +156% Return to IV: -61.0%
Market implies +13.3%/yr vs model +4.0% · above model
ANPA
Rich Sparkle Holdings Ltd
Valuation N/A
Technology
Price$1.91
Model IV—
P/IV—
Market implies +18.9%/yr
ANSC
ANSC
Valuation N/A
Price$11.46
Model IV—
P/IV—
Limited data — see page
ANSCU
ANSCU
Valuation N/A
Price$11.69
Model IV—
P/IV—
Limited data — see page
ANSCW
ANSCW
Valuation N/A
Price$0.00
Model IV—
P/IV—
Limited data — see page
ANSS
ANSS
Valuation N/A
Price$374.30
Model IV—
P/IV—
Limited data — see page
ANTA
Antalpha Platform Holding Co
Undervalued
Financial Services
Price$2.37
Model IV$2.99
P/IV0.77
Discount 21% Return to IV: +26.3%
ANTX
AN2 Therapeutics, Inc.
Valuation N/A
Healthcare
Price$4.40
Model IV—
P/IV—
Limited data — see page
ANVS
Annovis Bio, Inc.
Valuation N/A
Healthcare
Price$1.21
Model IV—
P/IV—
Limited data — see page
ANY
DarkHorse Technologies Inc.
Fairly valued
Financial Services
Price$2.75
Model IV$2.45
P/IV1.18
Premium +12% Return to IV: -10.8%
Market implies +2.7%/yr vs model +31.7% · below model
AOMR
Angel Oak Mortgage REIT, Inc.
Valuation N/A
Real Estate
Price$7.26
Model IV—
P/IV—
Limited data — see page
AOUT
American Outdoor Brands, Inc.
Deeply overvalued
Consumer Cyclical
Price$16.50
Model IV$8.16
P/IV2.04
Premium +102% Return to IV: -50.5%
Market implies +10.5%/yr vs model +2.0% · above model
AOXY
ADVANCED OXYGEN TECHNOLOGIES INC
Deeply undervalued
Real Estate
Price$0.09
Model IV$0.16
P/IV0.48
Discount 44% Return to IV: +78.0%
Market implies -9.4%/yr vs model +4.5% · below model